Abstract：Objective To study the clinical effect of CT-guided percutaneous microwave ablation (MWA) on treatment of early primary hepatic carcinoma. Methods A total of 86 early primary hepatic carcinoma patients treated in our hospital from January 2013 to July 2016 were selected as research subjects.According to the computer random method,patients were assigned to intervention group (43 cases) and control group (43 cases).The intervention group was treated with CT-guided percutaneous MWA, the control group was treated with conventional transcatheter arterial chemoembolization.The short-term efficacy, long-term efficacy and adverse reactions were compared. Results The total effective rate in intervention group was 81.40%, which was higher than that of control group (55.81%), with statistically significant difference (P＜0.05).The total incidence of adverse reactions between groups showed no statistically significant difference (P＞0.05).One-year survival rate between groups showed no statistically significant difference (P＞0.05).Twoyear and three-year survival rates in intervention group were higher than those of control group, with statistically significant differences (P＜0.05). Conclusion For early primary hepatic carcinoma patients, CT-guided percutaneous MWA has better short-term and long-term efficacy, and lower adverse event rate.
Henrie AM，Wittstrom K，Delu A，et al.Evaluation of liver biomarkers as prognostic factors for outcomes to Yttrium-90 radioembolization of primary and secondary liver malignancies[J].Cancer Biother Radiopharm，2015，30（7）：305-309.
Li M，Yu X，Liang P，et al.Ultrasound-guided percutaneous microwave ablation for hepatic malignancy adjacent to the gallbladder[J].Int J Hyperthermia，2015，31（6）：579-587.
京公网安备 11010502046607号